Drug · DIN 02557061
TEPEZZA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 23, 2026; first marketed January 23, 2026.
- Drug Identification Number (DIN)
- 02557061
- Company (DIN owner)
- Amgen Canada IncMississauga, Ontario, Canada
- Schedule
- Prescription; Schedule D
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Teprotumumab L04AG13
- Class
- Human
- Record last updated
- February 13, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TEPROTUMUMAB | 500 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 17, 2025: NOC 35253New Drug Submission (NDS)